$PRGO

PERRIGO Co plc

NYSE · Healthcare · Pharmaceutical Preparations · Dublin 2, Ireland

PRGO chart

What traders are saying about $PRGO

Latest posts

PERRIGO Co plc news

PERRIGO Co plc key financials

USD2025202420232022
Revenue$4.25B$4.37B$4.66B$4.45B
Net income-$1.43B-$171.8M-$12.7M-$140.6M
Diluted EPS$-10.29$-1.25$-0.09$-1.04
Total assets (year end)$8.54B$9.65B$10.81B$11.02B
Cash and equivalents (year end)–$558.8M$751.3M$600.7M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 10-Q10-Q
  • 8-K8-K
  • 8-K/A8-K/A
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K

About PERRIGO Co plc

Ticker
PRGO (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Dublin 2, Ireland
Incorporated in
Ireland
Fiscal year end
December 31
SEC CIK
1585364
Former names
PERRIGO Co Ltd

Frequently asked questions

What exchange is PERRIGO Co plc listed on?

PERRIGO Co plc trades on the NYSE under the ticker symbol PRGO.

What industry is PERRIGO Co plc in?

PERRIGO Co plc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is PERRIGO Co plc headquartered?

PERRIGO Co plc's business address on file with the SEC is in Dublin 2, Ireland.

When does PERRIGO Co plc's fiscal year end?

PERRIGO Co plc's fiscal year ends on December 31.

How much revenue did PERRIGO Co plc report?

PERRIGO Co plc reported $4.25B in revenue for calendar year 2025, according to its SEC filings.